Most patients have positive views about the ability of artificial intelligence (AI) to improve care but have concerns about unintended consequences, according to a research letter published online May 4 in JAMA Network Open.
May 13, 2022
0
2
Coronavirus-like particles (CoVLP), which are produced in plants, combined with an adjuvant (Adjuvant System 03 [AS03]) forms a candidate vaccine that is effective for preventing COVID-19, according to a study published online ...
May 5, 2022
0
63
Among patients with Lennox-Gastaut syndrome (LGS), the percentage reduction in the frequency of drop seizures is greater with fenfluramine versus placebo, according to a study published online May 2 in JAMA Neurology.
May 2, 2022
0
14
The incidence of Guillain-Barré syndrome (GBS) is increased after Ad.26.COV2.S vaccination, but incidence is not increased after mRNA vaccination, according to a study published online April 26 in JAMA Network Open.
Apr 27, 2022
0
60
A single dose of AZD7442 is effective for preventing COVID-19, according to a study published online April 20 in the New England Journal of Medicine.
Apr 22, 2022
0
5
Almost one in three patients surviving a stroke of unknown cause have atrial fibrillation (AF) detectable using continuous cardiac monitoring, according to a study presented at the annual meeting of the European Heart Rhythm ...
Apr 5, 2022
0
5
The vaccine effectiveness (VE) of Ad26.COV2.S was stable over six months, including during a period of delta variant predominance, according to a study published online March 17 in JAMA Network Open.
Mar 22, 2022
0
3
For patients with previously untreated metastatic or unresectable melanoma, the combination of relatlimab + nivolumab continues to demonstrate a progression-free survival (PFS) benefit over nivolumab alone, according to updated ...
Mar 21, 2022
0
13
For nonhospitalized patients with symptomatic mild-to-moderate COVID-19 and a high risk for progression, risk for all-cause hospitalization or death is reduced with sotrovimab versus placebo, according to a study published ...
Mar 18, 2022
0
12
(HealthDay)—Daily oral perampanel is generally well tolerated, with favorable retention rates among patients with epilepsy aged 1 to younger than 18 years, according to a study recently published in the Journal of Child ...
Mar 17, 2022
0
7
